论文部分内容阅读
目的观察释放左炔诺孕酮的宫内节育器(曼月乐)在子宫腺肌病治疗中的效果。方法观察32例子宫腺肌病患者(M组)放置曼月乐前后痛经和月经量的变化;同时选取相似病例34例,服用散结镇痛胶囊作为对照组(C组)。对其止痛减少经量的效果进行比较。结果治疗12个月后,M组痛经缓解率87.5%(28/32),明显高于C组的35.3%(12/34)(P<0.01);M组月经量明显减少[(138.8±36.7)mlvs.(11.1±3.1)ml](P<0.01),C组几乎无减少[(137.8±37.7)mlvs.(136.6±3.2)ml]。两组均未见严重不良反应。结论曼月乐治疗子宫腺肌病有效、安全。
Objective To observe the effect of levonorgestrel-releasing intrauterine device (Mirena) in the treatment of adenomyosis. Methods The changes of dysmenorrhea and menstrual flow in 32 cases of adenomyosis (M group) before and after the administration of Mirena were observed. Meanwhile, 34 cases of similar cases were selected and Sanjiezhitong capsule was taken as control group (C group). Their analgesic effect of reducing the amount of the comparison. Results After 12 months of treatment, the rate of relieving dysmenorrhea in group M was 87.5% (28/32), significantly higher than that in group C (35.3%, 12/34) (P <0.01) ) (11.1 ± 3.1) ml] (P <0.01), and there was almost no decrease in group C [(137.8 ± 37.7) ml vs (136.6 ± 3.2) ml]. No serious adverse reactions were seen in both groups. Conclusion Mirena treatment of adenomyosis effective and safe.